Table: begin end state 1 19 cytoplasmic 20 41 transmembrane 42 46 non-cytoplasmic 47 66 transmembrane 67 87 cytoplasmic 88 113 transmembrane 114 123 non-cytoplasmic 124 145 transmembrane 146 154 cytoplasmic 155 179 transmembrane 180 198 non-cytoplasmic 199 222 transmembrane 223 240 cytoplasmic 241 260 transmembrane 261 281 non-cytoplasmic 282 305 transmembrane 306 332 cytoplasmic 333 354 transmembrane 355 360 non-cytoplasmic 361 382 transmembrane 383 402 cytoplasmic 403 421 transmembrane 422 426 non-cytoplasmic 427 448 transmembrane 449 468 cytoplasmic
Input: >WP_015927628.1 NCBI__GCF_000022085.1:WP_015927628.1 MPLQTEHDPRLKRSLKTRHLTMISLGGVIGAGLFVGSSAIINSAGPGAFITYAITGVLVM LIMRMLGEMASARPTTGSFTDYSRMALGNWAGFSTGWMYWYFWVIVVGFEAVVGGQIING WFPIVPVWAISLALMVVMTVVNLLSVGSFGEAEYWFAGIKVVAIVVFLAIAGMYISGFWP DSKASFSNLTAHGGFFPNGIATLFSGVVVVIFSMTGVEVATIAAAESAEPVHNVRRAVNT VMFRIMTFFVLSVFLIAVIQPWNTVVPGKSPFVTTLDTIGIPGSGTMLTGIILVAVLSVL NAGLYTSSRLLFVLSSNGEAPRWIAQVNRRGVPVRGVLASTVVGYVCVVIAALWPDTVFQ FLINSSGAVILFVYLMICVSQIRLRRYWEQEGLLKFRMWGHPWLPLLVTGALAAVLISMA VDPSTRASLLQSLFAVAVILAAFGVLRFVRSGSLRGAHVPAGERKLVS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server